MULTI-TILE LIMITED

Financial Health Score: B- (Incomplete Examination)

Explanation: While the patient exhibits excellent outward signs of corporate hygiene and structural health, the absence of quantitative financial vitals (profit & loss, balance sheet details) means a full physical is impossible. The strong corporate lineage and flawless compliance history earn a high baseline score, but the lack of visible financial muscle prevents an 'A' grade.

1. Key Vital Signs (Critical Metrics & Interpretation)

• Pulse (Corporate Status): Active & Long-Standing. Incorporated in 1964, this company has a remarkably strong heartbeat, having survived numerous economic cycles for over 60 years. There are no signs of corporate cardiac arrest (liquidation or administration).
• Blood Pressure (Filing Compliance): 120/80 (Healthy). The company’s accounts and confirmation statements are up to date with Companies House, with nothing overdue. This indicates a well-regulated corporate nervous system and low stress from regulatory penalties.
• Immune System (Ownership & Control): Robust. The company is heavily inoculated by its parent entities, Topps Tiles Plc and Topps Tile Kingdom Limited, who hold more than 75% of shares and voting rights. This group backing acts as a powerful corporate immune system, ready to fight off sudden financial infections.
• Weight/BMI (Financial Mass): Unmeasured. The specific financial figures (assets, liabilities, cash flow) are missing from this chart. The only metric visible is a share capital of £235, which is practically weightless and suggests the company operates with minimal equity, likely sustained by inter-company "IV drips" (loans) from its parent.
• Reflexes (Officer Movements): Slight Twitch. There have been recent changes at the board level, with two directors resigning in late 2025 and mid-2026. One of these dates appears to be a futuristic anomaly, but changes in the cerebral cortex (leadership) always warrant monitoring for underlying strategic shifts.

2. Symptoms Analysis

Because the quantitative blood work (detailed financial statements) is unavailable, we must diagnose based on outward symptoms and corporate posture:

• Symptom of Group Dependency: The £235 share capital is microscopic for a retail entity. This is a classic symptom of a subsidiary that operates as a thin-capitalized shell or a brand-holding entity, relying on the parent group's circulatory system for working capital.
• Symptom of Regulatory Health: Filing as an "Audit Exemption Subsidiary" is a healthy, normal symptom for a company wrapped inside a larger group. It means the parent group provides the overarching financial governance, saving this entity from the costly and stressful audit process.
• Symptom of Dormant Potential: Given the lack of visible trading metrics and the tiny share capital, there is a chance this company is operating in a near-dormant state, acting merely as a legal vessel for the Topps Tiles brand or specific assets, rather than a heavy-lifting trading subsidiary.

3. Diagnosis

Diagnosis: Structurally Sound, Quantitatively Obscured Group Subsidiary

The patient is a healthy, compliant, and well-protected limb of the larger Topps Tiles corporate body. It shows no symptoms of distress, insolvency, or regulatory neglect. However, because the company files as an exempt subsidiary, its individual financial vitals are shielded from the public chart. The micro-share capital indicates it does not carry the financial weight of the group on its own shoulders; rather, it is financially tethered to its parent. The recent changes in directorship suggest a routine reshuffling of the corporate cortex rather than a symptom of internal decay.

4. Recommendations

To improve the financial wellness and transparency of this entity, I recommend the following prescriptions:

1. Order a Full Blood Panel: To truly assess the financial health of this patient, the internal management must review the unfiled, detailed group accounts. Relying solely on the public small-company balance sheet provides an incomplete diagnosis.
2. Monitor the Inter-Company IV: With only £235 in share capital, the company is entirely dependent on parent-group funding. Management should ensure that inter-company loans are properly documented and that the company can service any associated interest without causing group-wide financial strain.
3. Post-Board Checkup: Following the recent director resignations, ensure that the remaining directors (Browne and Jensen) have full oversight of the company's operational health, and that the corporate knowledge transfer was seamless.